- Home
- BCML vs CATX Comparison
BCML vs CATX Comparison
Compare BCML & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCML | CATX |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.8M | 341.0M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BCML | CATX |
|---|---|---|
| Price | $31.07 | $3.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $34.00 | $12.11 |
| AVG Volume (30 Days) | 45.2K | ★ 1.1M |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | ★ 3.81 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.71 | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | $282.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.78 | $1.96 |
| 52 Week High | $34.98 | $6.16 |
Technical Indicators
Market Signals| Indicator | BCML | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 54.84 |
| Support Level | $27.80 | $2.82 |
| Resistance Level | $32.86 | $4.27 |
| Average True Range (ATR) | 0.78 | 0.17 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 75.79 | 83.05 |
Price Performance
Historical ComparisonAbout BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.